Ontology highlight
ABSTRACT: Objective
To study the effect of familial Alzheimer disease (FAD) mutations and APOE genotype on plasma signaling protein levels.Design
Cross-sectional comparison of plasma levels of 77 proteins measured using multiplex immune assays.Setting
A tertiary referral dementia research center.Participants
Thirty-three persons from families harboring PSEN1 or APP mutations, aged 19 to 59 years.Main outcome measures
Protein levels were compared between FAD mutation carriers (MCs) and noncarriers (NCs) and among APOE genotype groups, using multiple linear regression models.Results
Twenty-one participants were FAD MCs and 12 were NCs. Six had the APOE ε2/3, 6 had the ε3/4, and 21 had the ε3/3 genotype. Levels of 17 proteins differed among APOE genotype
SUBMITTER: Ringman JM
PROVIDER: S-EPMC3668092 | biostudies-literature | 2012 Jun
REPOSITORIES: biostudies-literature